Matches in Nanopublications for { ?s ?p "[We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP346809.RAROh8RSGxEkq1QK5VSecwN8xes70260wFlWYTLSTj3Qo130_assertion description "[We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346809.RAROh8RSGxEkq1QK5VSecwN8xes70260wFlWYTLSTj3Qo130_provenance.
- assertion description "[We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP745894.RA2t1fcz3pPLmdss0XvohE0DkG2uLy_o44oljsGCkqs5E130_assertion description "[We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP745894.RA2t1fcz3pPLmdss0XvohE0DkG2uLy_o44oljsGCkqs5E130_provenance.
- NP663963.RAef0tV0zPV2GDg5f1eG9B6wEfO-lA-0KNNEqOI14RQBM130_assertion description "[We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663963.RAef0tV0zPV2GDg5f1eG9B6wEfO-lA-0KNNEqOI14RQBM130_provenance.
- assertion description "[We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP917269.RAb5TuBExxCXapNCBw7f_pWigiN2RwmklzPmlZ_R4WKdk130_assertion description "[We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917269.RAb5TuBExxCXapNCBw7f_pWigiN2RwmklzPmlZ_R4WKdk130_provenance.
- NP917271.RAsjY8Y79dv6txw09RSq-WqE4R_OlMaSbL8hBo80CMkMI130_assertion description "[We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917271.RAsjY8Y79dv6txw09RSq-WqE4R_OlMaSbL8hBo80CMkMI130_provenance.
- NP889473.RA4fggJ755V7K73ZZ5ZzWKEC8E1f275N_4HmtjGVdMnkg130_assertion description "[We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP889473.RA4fggJ755V7K73ZZ5ZzWKEC8E1f275N_4HmtjGVdMnkg130_provenance.
- NP917270.RAzNTEffy8R6JdyQRdLf41iQrUwa55GwiQUST-jSRjQxo130_assertion description "[We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917270.RAzNTEffy8R6JdyQRdLf41iQrUwa55GwiQUST-jSRjQxo130_provenance.